Drug intelligence / Profile preview

Immuno-oncology Program (Chimeron Bio)

Development stage
Preclinical
Lead developer
Chimeron Bio
Modality
Gene Therapies, Nanoparticles → Drug Delivery Systems, RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Injection
01

Overview

Chimeron Bio's Immuno-oncology Program is an in vivo gene therapy approach designed to modulate the tumor immune microenvironment (TIME) to restore anti-tumor immune surveillance. The program utilizes the company's proprietary MultiPlex RNA delivery platform, which is based on 'Chaomer' technology—self-assembling RNA nanoparticles. This platform enables the coordinated delivery and expression of multiple genes targeting various immune pathways simultaneously. The therapy is designed to provide weeks-long therapeutic activity from a single administration, featuring precise targeting and enhanced cellular uptake to drive the elimination of cancer cells while potentially overcoming the limitations of traditional systemic immunotherapies.

Other names
MultiPlex Immuno-oncology ProgramChimeron Bio Immuno-oncology Program

Beyond the preview

Go deeper on Immuno-oncology Program (Chimeron Bio).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immuno-oncology Program (Chimeron Bio).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call